Taxotere hair loss suits were sent to the U.S. District Court for the Eastern District of Louisiana (In re Taxotere (Docetaxel) Prod. Liab. Litig., J.P.M.L., No. 2740, 10/4/16).
Plaintiffs sued French drugmaker Sanofi S.A., subsidiary Sanofi-Aventis U.S. LLC and related companies, alleging they weren’t warned that the breast cancer drug could cause permanent hair loss.
The defendants were aware of this possible side effect and failed to warn patients, they allege. They also allege that the drugmakers marketed Taxotere as more effective than other chemotherapy treatments when other drugs were ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.